Australia markets close in 3 hours 24 minutes

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.86+0.01 (+0.07%)
At close: 01:00PM EST
14.86 0.00 (0.00%)
After hours: 01:01PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 993.42M
Enterprise value 571.03M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.37
Enterprise value/revenue N/A
Enterprise value/EBITDA -4.24

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 36.60%
S&P500 52-week change 3-13.51%
52-week high 319.93
52-week low 310.41
50-day moving average 314.62
200-day moving average 315.04

Share statistics

Avg vol (3-month) 31.03M
Avg vol (10-day) 3847.98k
Shares outstanding 566.9M
Implied shares outstanding 6N/A
Float 847.9M
% held by insiders 12.71%
% held by institutions 1108.39%
Shares short (14 Nov 2022) 46.98M
Short ratio (14 Nov 2022) 45.67
Short % of float (14 Nov 2022) 410.65%
Short % of shares outstanding (14 Nov 2022) 410.44%
Shares short (prior month 13 Oct 2022) 47.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-17.06%
Return on equity (ttm)-28.42%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -137.03M
Net income avi to common (ttm)-135.47M
Diluted EPS (ttm)-1.99
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)427.78M
Total cash per share (mrq)6.39
Total debt (mrq)5.38M
Total debt/equity (mrq)1.28
Current ratio (mrq)17.64
Book value per share (mrq)6.27

Cash flow statement

Operating cash flow (ttm)-106.9M
Levered free cash flow (ttm)-60.57M